Latest Updates
-
World Breastfeeding Week 2026: Beyond The First Feed—Why Early Support Matters For Mother And Baby -
The Mental Health Side Of Breastfeeding No One Really Talks About: What An Expert Wants You To Know -
Who Is Shreya Kalra? Meet The Lock Upp Season 2 Winner Who Took Home ₹1 Crore, Beating Shivangi Joshi -
Chandipura Virus Outbreak In Gujarat: 22 Children Dead; Expert Explains Symptoms, Prevention And Treatment -
Who Is Mini Mathur? Meet The Alliance Winner Who Beat Aly Goni To Win ₹50 Lakh Cash Prize -
Throwback Thursday: 6 Reasons 'Jaane Tu... Ya Jaane Na' Was Secretly Gen Z Before Gen Z Existed -
Hiroshima Day: Five Medical Discoveries That Emerged From One of History's Greatest Tragedies -
Why Young Adults Ignore Persistent Swelling for Months — And When It May Be Sarcoma -
Bigg Boss 20 Premiere Date Out: Salman Khan's Karan Arjun Tease Sparks SRK Buzz -
India's 101st Ramsar Site: What's Special About Arunachal Pradesh's Glaw Lake
Synthetic Molecules
Two researchers at Hebrew University of Jerusalem have designed synthetic molecules that may have future implications for the development of a new family of anti-cancer drugs.
The researchers successfully reduced and even removed the growth of human malignant tissues in mice, without any toxic effects on normal tissue.
This work, by Dr. Arie Dagan and Prof. Shimon Gatt of the Department of Biochemistry of the Hebrew University-Hadassah Medical School, won the Kaye Award for Innovation during the 71st meeting of the Hebrew University of Jerusalem Board of Governors.
These molecules greatly influence the metabolism of various sphingolipids and consequently those of cancer cells. Sphingolipids are a family of complex lipid molecules that are involved in signalling pathways that arbitrate cell growth, differentiation and death.
A number of the most active molecules developed by Dagan and Gatt are derivatives of ceramide (a member of the sphingolipid family), which initiates programmed cell death (apoptosis) in a variety of cancer cells.
Usually, the levels of ceramide in cancer cells are quite low to induce a therapeutic effect. However, in preclinical studies till date, many treatments with the synthetic molecules led to increased ceramide levels in cancer cells, thereby causing their death by apoptosis. Besides, these synthetic molecules appear to be synergistic with chemotherapeutic drugs.
The researchers said that their studies showed that their synthetic compounds significantly reduced the sizes of pancreatic, prostate and breast tumors with little or no effects on normal cells and tissues.
In their view, this is a precursor to the development of a new generation of anti-cancer drugs that induce, selectively, apoptosis only to tumorous cells. These drugs are expected to be highly effective while inducing fewer side effects than current anti-cancer drugs.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications